If hyaluronidase injections can be used on fibrotic scars to break down the connective tissues that give it height and volume, why can they not be used to address areas of overfill caused by Sculptra? I understand that hyaluronidase cannot target the Sculptra PLLA particles, but in cases of overcorrection, can’t the hyaluronidase technically provide some degree of minor volume reduction if it can breakdown components of the ECM? Won't it produce at least some reduction?